Beneficial effect of new thiol protease inhibitors, epoxide derivatives, on dystrophic mice
- 28 January 1986
- journal article
- research article
- Published by Elsevier in Experimental Neurology
- Vol. 91 (1), 23-29
- https://doi.org/10.1016/0014-4886(86)90022-1
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and LBiochemical Journal, 1982
- Susceptibilities of Various Myofibrillar Proteins to Cathepsin B and Morphological Alteration of Isolated Myofibrils by This Enzyme1The Journal of Biochemistry, 1981
- Inhibitions of degradation of rat liver aldolase and lactic dehydrogenase by N-[N-(L-3-trans-carboxyoxirane-2-carbonyl)-L-leucyl]agmatine or leupeptin in vivoBiochemical and Biophysical Research Communications, 1980
- Increased calcium-activated neutral protease activity in muscles of dystrophic hamsters and miceJournal of the Neurological Sciences, 1979
- Treatment of Mouse Muscular Dystrophy with the Protease Inhibitor PepstatinJournal of Neuropathology and Experimental Neurology, 1978
- Leupeptin, a Protease Inhibitor, Decreases Protein Degradation in Normal and Diseased MusclesScience, 1978
- Serine Protease in Mice with Hereditary Muscular Dystrophy1The Journal of Biochemistry, 1978
- Isolation and characterization of E-64, a new thiol protease inhibitor.Agricultural and Biological Chemistry, 1978
- A calcium-activated neutral protease in normal and dystrophic human muscleClinica Chimica Acta; International Journal of Clinical Chemistry, 1976
- Serum enzyme studies in muscle disease: Part III Serum creatine kinase activity in relatives of patients with the Duchenne type of muscular dystrophyJournal of Neurology, Neurosurgery & Psychiatry, 1964